The global cancer cachexia therapeutics market demonstrates significant growth, driven by the rising prevalence of cancer worldwide and a flourishing demand for effective treatment options. Cachexia, a debilitating syndrome characterized by severe weight loss and muscle wasting, affects a significant proportion of cancer patients, considerably impa